» Articles » PMID: 36985218

Synergistic Antibacterial Proficiency of Green Bioformulated Zinc Oxide Nanoparticles with Potential Fosfomycin Synergism Against Nosocomial Bacterial Pathogens

Overview
Journal Microorganisms
Specialty Microbiology
Date 2023 Mar 29
PMID 36985218
Authors
Affiliations
Soon will be listed here.
Abstract

The drug resistance of bacterial pathogens causes considerable morbidity and death globally, hence there is a crucial necessity for the development of effective antibacterial medicines to address the antibacterial resistance issue. The bioprepared zinc oxide nanoparticles (ZnO-NPs) were prepared utilizing the flower extract of and then characterized using different physicochemical techniques. The antibacterial effectiveness of the bioprepared ZnO-NPs and their synergism with fosfomycin were evaluated using disk diffusion assay against the concerned pathogens. Transmission electron microscopy (TEM) investigation of the bioprepared ZnO-NPs showed that their average particle size was 18.93 ± 2.65 nm. expressed the highest sensitivity to the bioinspired ZnO-NPs with a suppressive zone of 22.54 ± 1.26 nm at a concentration of 50 µg/disk, whereas the maximum synergistic effect of the bioinspired ZnO-NPs with fosfomycin was noticed against strain with synergism ratio of 100.29%. In conclusion, the bioinspired ZnO-NPs demonstrated significant antibacterial and synergistic efficacy with fosfomycin against the concerned nosocomial bacterial pathogens, highlighting the potential of using the ZnO NPs-fosfomycin combination for effective control of nosocomial infections in intensive care units (ICUs) and health care settings. Furthermore, the biogenic ZnO-NPs' potential antibacterial action against food pathogens such as and indicates their potential usage in food packaging applications.

Citing Articles

Cutting-edge developments in zinc oxide nanoparticles: synthesis and applications for enhanced antimicrobial and UV protection in healthcare solutions.

Irede E, Awoyemi R, Owolabi B, Aworinde O, Kajola R, Hazeez A RSC Adv. 2024; 14(29):20992-21034.

PMID: 38962092 PMC: 11220610. DOI: 10.1039/d4ra02452d.


Large-scale production of myco-fabricated ZnO/MnO nanocomposite using endophytic Colonstachys rosea with its antimicrobial efficacy against human pathogens.

El-Moslamy S, Abd-Elhamid A, El Fawal G Sci Rep. 2024; 14(1):935.

PMID: 38195769 PMC: 10776836. DOI: 10.1038/s41598-024-51398-9.


Synergistic antibacterial activity of Phyllanthus emblica fruits and its phytocompounds with ampicillin: a computational and experimental study.

Saini R, Kumar V, Patel C, Sourirajan A, Dev K Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(2):857-871.

PMID: 37522914 DOI: 10.1007/s00210-023-02624-0.


Biosorption of Using ZnO-Trimethyl Chitosan Nanocomposite Hydrogel Formed by the Green Synthesis Route.

Bwatanglang I, Mohammad F, Janet J, Dahan W, Al-Lohedan H, Soleiman A Gels. 2023; 9(7).

PMID: 37504460 PMC: 10378975. DOI: 10.3390/gels9070581.


Green Biofabrication of Silver Nanoparticles of Potential Synergistic Activity with Antibacterial and Antifungal Agents against Some Nosocomial Pathogens.

Al-Otibi F, Taha Yassin M, Al-Askar A, Maniah K Microorganisms. 2023; 11(4).

PMID: 37110368 PMC: 10144991. DOI: 10.3390/microorganisms11040945.

References
1.
Abbasi B, Iqbal J, Ahmad R, Zia L, Kanwal S, Mahmood T . Bioactivities of Leaf Extracts Conjugated with Zinc Oxide Nanoparticles. Biomolecules. 2020; 10(1). PMC: 7022592. DOI: 10.3390/biom10010038. View

2.
Gad El-Rab S, Abo-Amer A, Asiri A . Biogenic Synthesis of ZnO Nanoparticles and Its Potential Use as Antimicrobial Agent Against Multidrug-Resistant Pathogens. Curr Microbiol. 2020; 77(8):1767-1779. DOI: 10.1007/s00284-020-01991-8. View

3.
Irfan M, Munir H, Ismail H . Moringa oleifera gum based silver and zinc oxide nanoparticles: green synthesis, characterization and their antibacterial potential against MRSA. Biomater Res. 2021; 25(1):17. PMC: 8106117. DOI: 10.1186/s40824-021-00219-5. View

4.
Terreni M, Taccani M, Pregnolato M . New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives. Molecules. 2021; 26(9). PMC: 8125338. DOI: 10.3390/molecules26092671. View

5.
Moravej H, Moravej Z, Yazdanparast M, Heiat M, Mirhosseini A, Moosazadeh Moghaddam M . Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. Microb Drug Resist. 2018; 24(6):747-767. DOI: 10.1089/mdr.2017.0392. View